Former government health officials fear the Trump administration is moving to slow-walk vaccine approvals, including by ...

There’s new uncertainty about updated COVID-19 shots this fall after the Trump administration’s handling of a shot from ...

Comments over the weekend by FDA chief Martin Makary suggest the agency views Novavax’s updated COVID shot as a “new product” ...

The news sent the stock of South San Francisco' Vaxart Inc. (Nasdaq: VXRT) nearly 17% higher Monday morning, or 6.7 cents, to ...

Novavax’s COVID-19 vaccine could soon receive full approval from the United States Food and Drug Administration.

Confusion over the FDA delay in granting full approval to Novavax’s Covid-19 vaccine deepened over the weekend, with possible ...